Chronic calcium channel blockade progression myocardial contractile electrical dysfunction cardiomyopathic Syrian hamster programmed onset myocardial dysfunction progression heart failure cardiomyopathic Syrian hamster alterations myocellular calcium regulation calcium channel blockade effective progressive depression myocardial contractile performance animal model congestive heart failure oral verapamil therapy days age treatment various durations time study days age Left ventricular papillary muscle isometric isotonic performance transmembrane electrical characteristics diseased hamsters days age days age changes prolongation contraction duration marked depression load-velocity relation significant prolongation repolarization phase transmembrane action potential Myocardial functional electrical alterations progression life myopathic hamsters verapamil therapy continuous days birth death diastolic arrest days age premature termination verapamil treatment death progressive renewal functional electrical alterations duration drug termination pathological changes lifetime cardiomyopathic hamster continuous calcium channel blockade intermediate prevention protracted verapamil therapy chronic verapamil therapy useful adjunct prevention human congestive heart failure similar etiology 